Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism LXR agonists(Liver X receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H15FN2O5 |
InChIKeyMVSDPJNCAUPGBR-UHFFFAOYSA-N |
CAS Registry1090785-30-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Preclinical | CN | 01 May 2016 | |
Atherosclerosis | Preclinical | CN | 01 May 2016 |